Clinical Trials Directory

Trials / Completed

CompletedNCT01801098

Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI

Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation With a Self-expanding Bioprosthesis

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The development of a high grade AV-block is a frequent complication associated with transcatheter aortic valve implantation (TAVI). Patients who were suitable for TAVI will be enrolled in this study. The HV-interval will be determined before and immediately after implantation. The hypothesis is that a prolonged HV-interval is associated with a high rate of complete AV-block following TAVI.

Conditions

Timeline

Start date
2012-12-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-02-28
Last updated
2013-11-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01801098. Inclusion in this directory is not an endorsement.

Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI (NCT01801098) · Clinical Trials Directory